Vascular-Associated Pluripotent Stem Cells Without Genetic Reprogramming
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and utilizing stem cells for regenerative therapies are limited by the need for genetic modification and lack of identification of universally distributed pluripotent stem cells capable of differentiating into all somatic cell types under environmental guidance.
Innovation Solution
Isolation and use of vascular-associated pluripotent stem cells (vaPS) that express markers such as NG2, Nestin, and others, which can differentiate into all three germ layers without genetic modification, guided by the microenvironment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods for isolating stem cells are used, then stem cells can be obtained for therapy, but genetic modification is required which increases complexity and potential harm
Solution Approach 1:
The patent extracts and utilizes the inherent pluripotent capacity of adult stem cells without requiring genetic modification. By isolating and culturing adult stem cells under specific conditions that maintain their undifferentiated state, the invention removes the need for genetic engineering while still achieving therapeutic pluripotent cell generation
Solution Approach 2:
The patent enables adult stem cells to self-differentiate into various cell types when transplanted into damaged tissues. The cells naturally respond to the microenvironmental cues at the injury site and differentiate autonomously without requiring external genetic programming, thus serving themselves rather than being externally controlled
2Ease of manufacture
If adult stem cells are used, then they are readily available, but they were believed to be committed to their tissue of origin and unable to differentiate into all cell types
Solution Approach 1:
The patent performs preliminary culturing and maintenance of adult stem cells in an undifferentiated state before transplantation. By keeping the cells in a pluripotent state through specific culture conditions and then transplanting them, the invention prepares the cells in advance to maintain their versatility while being readily available from adult tissues
Solution Approach 2:
The patent demonstrates that adult stem cells from various tissue origins can universally differentiate into multiple cell types across different germ layers when transplanted into damaged tissues. The cells adapt to the microenvironmental cues at the injury site and differentiate into the required cell types, showing multi-functionality beyond their tissue of origin
3Adaptability or versatility
If embryonic or induced pluripotent stem cells are used, then they have intrinsic pluripotency, but they require genetic reprogramming which increases complexity and potential harm
Solution Approach 1:
The patent extracts and utilizes the inherent pluripotent capacity of adult stem cells without requiring genetic modification. By isolating and culturing adult stem cells under specific conditions that maintain their undifferentiated state, the invention removes the need for genetic engineering while still achieving therapeutic pluripotent cell generation
Solution Approach 2:
The patent enables adult stem cells to self-differentiate into various cell types when transplanted into damaged tissues. The cells naturally respond to the microenvironmental cues at the injury site and differentiate autonomously without requiring external genetic programming, thus serving themselves rather than being externally controlled
Data Source
AI summary
A composition comprising isolated vascular-associated naturally pluripotent stem cells (vaPS), is disclosed, as well as method of treating defects using such composition, wherein said vaPS are capable of differentiating into somatic cells of all three germ layers under the guidance of the respective microenvironment.